Synthetic rewriting technologies in mammalian cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41530163.
- Also identified by DOI 10.1038/s41467-025-68066-9 and PMC identifier 12868904.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Synthetic rewriting technologies, encompassing large-scale DNA assembly, transfer, maintenance, and rearrangement, enabled de novo synthesis or large-scale modifications of genomes. While significant progress has been made in model organisms of viruses, bacteria, and unicellular eukaryotes, their development in mammalian cells faces unique challenges. This review summarizes key breakthroughs in synthetic rewriting technologies, including megabase (Mb)-scale assembly of human DNA, yeast-mediated transfer methods, bottom-up human artificial chromosomes (HACs), and genome-scale rearrangement, along with emerging applications in constructing models and decoding genomes for mammals. These tools will expand functional engineering in mammals and deepen mechanistic insights into complex biological systems.
Medical subject headings
- Synthetic Biology
- Genetic Engineering
- Gene Editing